C07D 213/69
Two or more oxygen atoms
C07D213/69 (Two or more oxygen atoms) appears on 579 US grants and 507 published applications in this corpus.
Search patents in C07D- Granted patents
- 579
- Published applications
- 507
- Assignees
- 298
- Inventors
- 1,905
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 11 | 0 |
| 1978 | 11 | 0 |
| 1979 | 12 | 0 |
| 1980 | 14 | 0 |
| 1981 | 5 | 0 |
| 1982 | 3 | 0 |
| 1983 | 5 | 0 |
| 1984 | 2 | 0 |
| 1985 | 4 | 0 |
| 1986 | 2 | 0 |
| 1987 | 6 | 0 |
| 1988 | 7 | 0 |
| 1989 | 13 | 0 |
| 1990 | 8 | 0 |
| 1991 | 10 | 0 |
| 1992 | 12 | 0 |
| 1993 | 10 | 0 |
| 1994 | 6 | 0 |
| 1995 | 8 | 0 |
| 1996 | 7 | 0 |
| 1997 | 8 | 0 |
| 1998 | 9 | 0 |
| 1999 | 10 | 0 |
| 2000 | 11 | 0 |
| 2001 | 12 | 1 |
| 2002 | 14 | 10 |
| 2003 | 10 | 16 |
| 2004 | 10 | 21 |
| 2005 | 8 | 12 |
| 2006 | 6 | 20 |
| 2007 | 7 | 15 |
| 2008 | 2 | 14 |
| 2009 | 12 | 19 |
| 2010 | 17 | 24 |
| 2011 | 17 | 19 |
| 2012 | 17 | 22 |
| 2013 | 17 | 19 |
| 2014 | 18 | 27 |
| 2015 | 25 | 32 |
| 2016 | 25 | 28 |
| 2017 | 19 | 27 |
| 2018 | 27 | 30 |
| 2019 | 22 | 32 |
| 2020 | 29 | 23 |
| 2021 | 14 | 19 |
| 2022 | 11 | 24 |
| 2023 | 15 | 19 |
| 2024 | 8 | 13 |
| 2025 | 11 | 12 |
| 2026 | 7 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Tautomeric ligand enables biomimetic C—H hydroxylation with molecular oxygen22 Sep 2026US 12,741,937 B2The Scripps Research Institute
- Direct aromatic carbon-oxygen and carbon-hydrogen bond functionalization via organic photoredox catalyst8 Sep 2026US 12,729,169 B2The University of North Carolina at Chapel Hill
- Phosphonate conjugates and uses thereof7 Apr 2026US 12,595,273 B2
- PD-1/PD-L1 inhibitors31 Mar 2026US 12,590,062 B2Gilead Sciences, Inc.
- Inhibitors of influenza virus replication3 Mar 2026US 12,565,488 B2Cocrystal Pharma, Inc.
- Phenyl-substituted heteroaryl compound and pharmaceutical composition comprising same, preparation method therefor and use thereof30 Jul 2026US 2026/0217652 A1Shanghai Meiyue Biotech Development Co., Ltd.
- Enhancer reagent for a chemiluminescence reaction and compound30 Jul 2026US 2026/0218043 A1FUJIFILM Corporation
- Phosphonate conjugates and uses thereof25 Jun 2026US 2026/0176295 A1The Translational Genomics Research Institute
- Novel compounds and uses thereof21 May 2026US 2026/0138956 A1Recursion Pharmaceuticals, Inc.
- Covalent, chemogenetic activators for k2p potassium channels and uses thereof9 Apr 2026US 2026/0098008 A1The Regents of the University of California
Most cited
By later US patents
- Intermediates for imidazo[4,5-c]pyridin-4-amines248US 5,446,153 AMinnesota Mining and Manufacturing Company · 1995
- Imidazo[4,5-C]pyridin-4-amines147US 5,494,916 AMinnesota Mining and Manufacturing Company · 1996
- Catecholamine surrogates useful as .beta..sub.3 agonists122US 5,776,983 ABristol-Myers Squibb Company · 1998
- Imidazo[4,5-c]pyridin-4-amine intermediates97US 5,644,063 AMinnesota Mining and Manufacturing Company · 1997
- Benzamidine derivatives and their use as anti-coagulants92US 5,691,364 ABerlex Laboratories, Inc. · 1997